Four retrospective observational studies were included, with only two cohort studies indicating a reduced risk, particularly with dulaglutide
Earlier SURMOUNT-1 data further reinforced these outcomes, with tirzepatide demonstrating weight loss of up to 22.5% of body weight over 72 weeks, the highest ever recorded for a pharmacological weight loss therapy at that time
Results and What to Expect with Ipamorelin Therapy Most patients begin to notice subtle improvementssuch as better sleep and increased energywithin the first month of starting ipamorelin treatment
Mechanisms underlying the anorexigenic effects of GLP-1 receptor agonists The anorexigenic effects of GLP-1RAs are primarily mediated by the activation of GLP-1Rs expressed in the brain
Inconsistent distribution patterns of GLP-1R in the hippocampus have been reported by different morphological studies (Cork et al., 2015
It also slows gastric emptying and delays digestion, which compounds that feeling of fullness